• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Nutraceuticals for Men: Muscle Health and Performance Nutrition

    Aging in Place: Healthy Lifestyles Supplement Science-Based Solutions

    Getting an Edge in Esports: Meeting the Health Needs of Competitive Gamers

    Beyond CBD: Cannabis Compounds Warrant Recognition and More Research

    Leveling Out the Energy Segment for Mainstream, and Rethinking Caffeine
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board

    Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission

    Choline Alone May Improve Maternal DHA Status During Pregnancy

    Cranberry Consumption Linked to Memory and Neurological Function Improvements
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board

    Choline Alone May Improve Maternal DHA Status During Pregnancy

    Cranberry Consumption Linked to Memory and Neurological Function Improvements

    Bilberon Bilberry Extract Receives U.S. Patent For Eye Strain, Neck/Shoulder Pain
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    FDA Issues Draft Guidance on NDI Enforcement Discretion

    GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board

    Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission

    Choline Alone May Improve Maternal DHA Status During Pregnancy
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board

    Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission

    Choline Alone May Improve Maternal DHA Status During Pregnancy

    Cranberry Consumption Linked to Memory and Neurological Function Improvements

    Bilberon Bilberry Extract Receives U.S. Patent For Eye Strain, Neck/Shoulder Pain
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Sabinsa Corporation

    Verdure Sciences

    Gencor

    Atlantia Clinical Trials

    PhytoGaia Inc
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Sabinsa Corporation

    Verdure Sciences

    Gencor

    Atlantia Clinical Trials

    PhytoGaia Inc
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    FDA Rejects Two New Dietary Ingredient Notifications for CBD

    The decision likely means the agency will not approve future NDIs for CBD barring a directive from Congress.

    FDA Rejects Two New Dietary Ingredient Notifications for CBD
    Related CONTENT
    • FDA Issues Draft Guidance on NDI Enforcement Discretion
    • Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board
    • Consumer Conviction: Results of consumer satisfaction study on mental wellness and sleep.
    • Bilberon Bilberry Extract Receives U.S. Patent For Eye Strain, Neck/Shoulder Pain
    • Jordan Process Receives Nutrasource ICAP Certification for CBD
    By Mike Montemarano, Associate Editor08.13.21
    The U.S. Food and Drug Administration rejected two New Dietary Ingredient Notifications (NDINs) for full-spectrum hemp extracts containing cannabidiol (CBD) submitted by manufacturers Charlotte’s Web and Irwin Naturals. According to industry stakeholders, the decision signifies that FDA does not intend to approve of the use of CBD as a dietary ingredient, and by default, doesn’t intend to regulate it as such.
     
    Notably, these were the first NDI notifications to receive a response from the FDA, making this a new development over the course of deliberations on where the ingredient stands.
     
    “Based on how FDA engaged these companies over the course of months—having meeting after meeting, request after request for more safety data—and then an invitation to submit NDI notifications, we’re certainly disappointed and surprised that FDA rejected the two NDI notifications,” Steve Mister, president and CEO of the Council for Responsible Nutrition, told Nutraceuticals World. “CRN handed FDA a playbook for creating a regulatory framework for CBD, and FDA punted the ball.”
     
    In each of the agency’s NDI responses, Cara Welch, PhD, acting director of the FDA’s Office of Dietary Supplement Programs stated that because CBD is an active ingredient in Epidiolex, an approved drug, hemp extracts that contain CBD cannot achieve regulatory status as a dietary supplement ingredient. Additionally, Welch mentioned in both letters to the respective CBD manufacturers that the studies they provided didn’t provide adequate data regarding certain endpoints, including hepatotoxicity and reproductive toxicity.
     
    “For these reasons, the information in your submission indicates that, even if your NDI 1202 were not excluded from the definition of a dietary supplement, your notification does not provide an adequate basis to conclude that a dietary supplement containing the ingredient, when used under the proposed conditions of use, would reasonably be expected to be safe,” Welch wrote in response to Charlotte’s Web.
     
    Mister said that he and stakeholders overwhelmingly disagree with hemp extracts’ characterization as the same “article” as Epidiolex. “FDA has wrongly mischaracterized these products as the same article as a prescription drug and has ignored, dismissed, and downplayed the ample evidence that these full-spectrum hemp products can be marketed in a manner that is reasonably expected to be safe.”
     
    “Epidiolex, manufactured by GW Pharma, is a highly-concentrated CBD isolate that contains 10-times more CBD than either of the full-spectrum hemp ingredients and plainly is not the same article supplement companies are producing,” Mister continued.

    He also voiced objection to FDA’s characterization of the safety data provided by the two companies as “insufficient.”

    Mister added that, because the FDA rejects CBD’s use as a legal dietary supplement ingredient, thus not considering it to be within its inspectional jurisdiction, the current marketplace for CBD products has no government oversight, leaving companies to self-regulate for the quality and safety of their own products.

    Daily Consumption Levels Not Mentioned 
    Daniel Fabricant, president and CEO of the Natural Products Association, said that setting a safe level of daily consumption for CBD products remains the best pathway for regulating the CBD marketplace.
     
    "Future NDI guidance without real clarity on cannabinoids, including CBD doesn’t help the millions of Americans who already believe FDA regulates the space," Fabricant said. The response to this NDI indicates that there is confusion and misunderstanding on all sides of the issue and it must be addressed by the forthcoming guidance. There have to be clear safety rules and thinking on these matters." 

    A bipartisan bill introduced in the Senate could clarify the NDI process and set a safe level of consumption for CBD products, as part of a larger cannabis reform effort. 

    NPA has been advocating for establishment of a safe level of daily CBD consumption in supplements since 2017. The trade organization drafted a bill which was passed, which provided resources for FDA to conduct a Health Hazard Evaluation on CBD in order to be able to set a safe level of daily consumption. 

    This process for CBD in full-spectrum hemp extracts could follow a similar pathway to market as red yeast rice, an ingredient which was originally subject to drug preclusion by FDA during the NDI process. Once a safe level of daily consumption for red yeast rice's constituents was established for dietary supplements, the agency no longer considered red yeast rice, in supplement-level quantities, to be precluded from the NDI process. 
     
    Calling on Congress
    CBD proponents argue that legal access to CBD as a dietary supplement ingredient, under the inspectional authority of FDA, was the intent of Congress when it passed the 2018 Farm Bill, which legalized the production of industrial hemp. Since then, industry stakeholders have called upon FDA to regulate CBD as a dietary ingredient.
     
    “Despite very clear direction from Congress when it removed hemp from the Controlled Substances Act in 2018, FDA seems to have made up its mind not to support CBD in supplements and is now trying to justify it,” Mister said.
     
    This far after the passage of the 2018 Farm Bill, as uncertainty still looms, Mister said it seems likely that the only way CBD will progress toward a dietary ingredient status is through lobbying Congress members to pass a bill that would require FDA to set aside its drug preclusion concerns for full-spectrum hemp extract, and to recognize CBD as a dietary ingredient for supplements. Certainly, trade groups will be lobbying for a bipartisan bill to do just that, while assuring FDA applies the same requirements for manufacturing, labeling, and marketing of other dietary supplements.
     
    “Today’s rejection letters disregard clear safety evidence and a distinction between the two forms and concentrations of CBD. So yes, it’s clear that Congress needs to step in to exclude CBD from the drug preclusion language,” Mister said. “FDA chose to disregard volumes of safety data presented by each submitter. FDA’s refusal to make distinctions between Epidiolex’s CBD isolate and the submitters’ full-spectrum hemp extract—different forms, different dosages, different indications, and the submitters not making any drug-like claims—makes it very clear that Congress must step in to resolve FDA’s unwillingness to act logically.”
     
    Mister noted that since CRN first urged the agency to act two years ago, consumer interest in CBD has grown, sales have multiplied, and product innovation has expanded. “Individual states have grown impatient and begun devising their own inconsistent patchwork of regulations. Meanwhile, FDA has turned its back on the safety of millions of Americans by refusing to take action on a legal pathway to marketing CBD. While most supplement companies follow good manufacturing practices (GMPs), bad actors do exist. FDA’s refusal to regulate the CBD marketplace opens the door to CBD products that may be poorly manufactured or illegally marketed.”
     
    Related Searches
    • Herbs & Botanicals
    • Quality & Safety
    • Regulations
    Related Knowledge Center
    • Herbs & Botanicals
    • Regulations
    • Quality & Safety
    Suggested For You
    FDA Issues Draft Guidance on NDI Enforcement Discretion FDA Issues Draft Guidance on NDI Enforcement Discretion
    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board
    Consumer Conviction: Results of consumer satisfaction study on mental wellness and sleep. Consumer Conviction: Results of consumer satisfaction study on mental wellness and sleep.
    Bilberon Bilberry Extract Receives U.S. Patent For Eye Strain, Neck/Shoulder Pain Bilberon Bilberry Extract Receives U.S. Patent For Eye Strain, Neck/Shoulder Pain
    Jordan Process Receives Nutrasource ICAP Certification for CBD Jordan Process Receives Nutrasource ICAP Certification for CBD
    Draft Senate Bill to Reauthorize FDA User Fees Includes Dietary Supplement Listing Provision Draft Senate Bill to Reauthorize FDA User Fees Includes Dietary Supplement Listing Provision
    FDA Warns About Steroids or Steroid-Like Substances in Bodybuilding Products  FDA Warns About Steroids or Steroid-Like Substances in Bodybuilding Products
    Nootropics and Adaptogens Respond to Demand for Mind and Mood Support Nootropics and Adaptogens Respond to Demand for Mind and Mood Support
    Sabinsa Honors 70th Anniversary of Diplomacy Between India and Japan Sabinsa Honors 70th Anniversary of Diplomacy Between India and Japan
    Experts Debate Role of Supplements in Improving Public Health in EU Experts Debate Role of Supplements in Improving Public Health in EU
    NSF and SCNM’s School of Nutrition Collaborate on Master of Science Program NSF and SCNM’s School of Nutrition Collaborate on Master of Science Program
    Walgreen’s Brand Vitamins and Supplements First to Carry UL Verified Mark Walgreen’s Brand Vitamins and Supplements First to Carry UL Verified Mark
    Leaven Essential to Launch Branded Botanical Extracts to Global Markets Leaven Essential to Launch Branded Botanical Extracts to Global Markets
    MR-10®: A Natural Botanical Ingredient Clinically-Proven to Alleviate Symptoms of Andropause MR-10®: A Natural Botanical Ingredient Clinically-Proven to Alleviate Symptoms of Andropause
    Nektium Secures International Patents for Zynamite Mango Leaf Extract Nektium Secures International Patents for Zynamite Mango Leaf Extract

    Related Content

    • Dietary Supplements | Regulations
      FDA Issues Draft Guidance on NDI Enforcement Discretion

      FDA Issues Draft Guidance on NDI Enforcement Discretion

      Amnesty for late NDI notifications is intended to encourage manufacturers and distributors to correct past failures while collecting safety data, FDA said.
      By Sean Moloughney, Editor 05.20.22

    • Breaking News | Dietary Supplements | Digestive Health | Immune Function | People News | Probiotics & Prebiotics
      Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board

      Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board

      In his new role, Hill will work to further advance the understanding and education surrounding postbiotics.
      05.19.22

    • Consumer Conviction: Results of consumer satisfaction study on mental wellness and sleep.

      Consumer Conviction: Results of consumer satisfaction study on mental wellness and sleep.

      Register now for our FREE Webinar on Wednesday, June 8, 2022; 10AM EST!
      05.18.22


    • Breaking News | Dietary Supplements | Eye Health | Herbs & Botanicals | Supplier News
      Bilberon Bilberry Extract Receives U.S. Patent For Eye Strain, Neck/Shoulder Pain

      Bilberon Bilberry Extract Receives U.S. Patent For Eye Strain, Neck/Shoulder Pain

      The anthocyanin-rich ingredient is now poised to enter the eye health category.
      05.18.22

    • Breaking News | Certifications, Approvals & Patents | Herbs & Botanicals | Quality & Safety | Testing
      Jordan Process Receives Nutrasource ICAP Certification for CBD

      Jordan Process Receives Nutrasource ICAP Certification for CBD

      The company was the first raw material provider to join the certification program.
      05.18.22

      Trending
      • Vitamin D3, Omega-3s, Exercise May Cumulatively Reduce Cancer Risk In Older Adults | Nutraceuticals World
      • Leaven Essential To Launch Branded Botanical Extracts To Global Markets | Nutraceuticals World
      • Vitamin D3, Omega-3s, Exercise May Cumulatively Reduce Cancer Risk in Older Adults
      • Oregon Files Lawsuit Against GNC | Nutraceuticals World
      • Vitamin K2 Status May Impact Blood Pressure And Pulse Wave Velocity | Nutraceuticals World
      Breaking News
      • GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe
      • Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board
      • Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission
      • Choline Alone May Improve Maternal DHA Status During Pregnancy
      • Cranberry Consumption Linked to Memory and Neurological Function Improvements
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • Aging in Place: Lifestyle Supplements Science-Based Solutions
      • Getting an Edge in Esports: Meeting Health & Nutrition Needs
      • Nutraceuticals for Men: Muscle Health and Performance Nutrition

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe
      Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board
      Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission
      Coatings World

      Latest Breaking News From Coatings World

      What Are You Reading?
      Teknos Receives EcoVadis Gold Medal for Sustainability Performance
      AkzoNobel and Partners Team Up to Hack Carbon Reduction Challenges
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      MPO's Most-Read Stories This Week—May 21
      Iterative Scopes Expands its Senior Leadership Team
      Viz.ai Raises $100 Million in Series D Funding
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Piramal Pharma Solutions New API Plant in Canada Now Online
      MG America Appoints Claudio Radossi as President
      Catalent Invests $175M to Expand Mfg. Capabilities at Winchester, KY
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Authentic Beauty Concept Launches Second-Generation ‘Refill Bar’
      HASK Beauty Enters Exclusive Partnership with Amazon
      Garance Doré Launches Made in France Skincare Line
      Happi

      Latest Breaking News From Happi

      P&G Closes HQ Due To Security Threat, Launches New Hair Care Line
      SPF Setting Spray, Lip Contour and Knotless Braids Are Hot Trends: Spate
      Nutrafol Launches Collagen Infusion
      Ink World

      Latest Breaking News From Ink World

      Weekly Recap: Zeller+Gmelin, Sun Chemical and Kornit Top This Week’s News
      Nazdar Celebrates 100 Years with a New Look
      hubergroup Chemicals Exhibits at Paint India for First Time
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Brook + Whittle's new acquisition, SunDance goes to HP and more
      Specialty announces move to new facility
      Mark Andy hosts dealer's open house in Warsaw
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Weekly Recap: Kimberly-Clark to Expand Diaper, Wipes Production in Brazil; The Honest Company to Sell Diapers, Wipes at Walmart & More
      3M to Expand in Nebraska
      Nicely Offers Nonwoven Slitters, Winders
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      ODT's Most Read Stories This Week—May 21
      FDA Clears Anika Therapeutics' X-Twist Knotless Fixation System
      Paragon 28 Rolls Out TenoTac 2.0 Hammertoe and Soft Tissue Repair
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Weekly Recap: Graphene Flagship, Japan Display and LG Display Top This Week’s Stories
      Evonik Launches New Processing Aids for PV Wafer Cutting
      NREL Creates Highest Efficiency 1-Sun Solar Cell

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login